TipRanks
Advertisement
Advertisement

LXEO Stock Latest News

Lexeo Therapeutics Reports Unregistered Equity Issuances Post-Merger
Company AnnouncementsLexeo Therapeutics Reports Unregistered Equity Issuances Post-Merger
23d ago
8K
LXEO
Lexeo Therapeutics enter into agreement to acquire Mantle Therapeutics
PremiumThe Fly
Lexeo Therapeutics enter into agreement to acquire Mantle Therapeutics
1M ago
LXEO
Lexeo Therapeutics expands FA pipeline with Mantle acquisition
PremiumCompany Announcements
Lexeo Therapeutics expands FA pipeline with Mantle acquisition
1M ago
8K
LXEO
Lexeo Therapeutics reports Q2 EPS (30c), consensus (28c)
PremiumThe Fly
Lexeo Therapeutics reports Q2 EPS (30c), consensus (28c)
2M ago
LXEO
Lexeo Therapeutics advances gene therapy and gains RMAT status
PremiumCompany Announcements
Lexeo Therapeutics advances gene therapy and gains RMAT status
2M ago
8K
LXEO
Lexeo Therapeutics management to meet with Cantor
PremiumThe FlyLexeo Therapeutics management to meet with Cantor
3M ago
LXEO
Lexeo’s SUNRISE-FA 2 Trial Puts Gene Therapy for Rare Heart Disease in Investor Focus
Premium
Company Announcements
Lexeo’s SUNRISE-FA 2 Trial Puts Gene Therapy for Rare Heart Disease in Investor Focus
3M ago
LXEO
Citizens biotech analysts hold an analyst/industry conference call
Premium
The Fly
Citizens biotech analysts hold an analyst/industry conference call
4M ago
BIIB
DSGN
Lexeo Shareholders Reelect Directors, Ratify KPMG Auditor
PremiumCompany Announcements
Lexeo Shareholders Reelect Directors, Ratify KPMG Auditor
4M ago
8K
LXEO
Lexeo Therapeutics price target lowered to $9 from $12 at JPMorgan
PremiumThe Fly
Lexeo Therapeutics price target lowered to $9 from $12 at JPMorgan
4M ago
LXEO
Lexeo finalizes SUNRISE-FA 2 pivotal trial protocol, statistical analysis plan
PremiumThe Fly
Lexeo finalizes SUNRISE-FA 2 pivotal trial protocol, statistical analysis plan
4M ago
LXEO
Lexeo Advances Pivotal LX2006 Trial for FA Cardiomyopathy
PremiumCompany Announcements
Lexeo Advances Pivotal LX2006 Trial for FA Cardiomyopathy
4M ago
8K
LXEO
Acting FDA head vows to block political interference, Endpoint News says
PremiumThe FlyActing FDA head vows to block political interference, Endpoint News says
5M ago
AZN
BMY
FDA issues draft guidance to help accelerated cell, gene therapies for patients
Premium
The Fly
FDA issues draft guidance to help accelerated cell, gene therapies for patients
5M ago
AZN
BMY
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
Premium
The Fly
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
5M ago
AZN
BMY
Trump Trade: U.S. plans AI security order without required model tests
PremiumThe Fly
Trump Trade: U.S. plans AI security order without required model tests
5M ago
DYN
RNA
Trump approves plan to fire FDA head Marty Makary, CBS reports
PremiumThe Fly
Trump approves plan to fire FDA head Marty Makary, CBS reports
5M ago
DYN
RNA
Lexeo Therapeutics reports Q1 EPS (25c), consensus (30c)
PremiumThe Fly
Lexeo Therapeutics reports Q1 EPS (25c), consensus (30c)
5M ago
LXEO
Lexeo Highlights Q1 Progress Advancing Cardiac Gene Therapies
PremiumCompany Announcements
Lexeo Highlights Q1 Progress Advancing Cardiac Gene Therapies
5M ago
8K
LXEO
Lexeo Therapeutics Adds Genomic Medicine Leader to Board
PremiumCompany AnnouncementsLexeo Therapeutics Adds Genomic Medicine Leader to Board
6M ago
8K
LXEO
Lexeo Therapeutics management to meet with Cantor Fitzgerald
Premium
The Fly
Lexeo Therapeutics management to meet with Cantor Fitzgerald
6M ago
LXEO
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
Premium
The Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
6M ago
DYN
RNA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >